Clearside Biomedical, Inc.CLSDNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank42
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P42
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
5 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -36.19% |
| 2023 | -35.69% |
| 2022 | -24.52% |
| 2021 | 18.19% |
| 2020 | 51.53% |
| 2019 | 65.82% |
| 2018 | -55.04% |
| 2017 | -124.95% |
| 2016 | -63.35% |
| 2015 | -52.37% |